文献速递产科母胎医学

病理诊断的胎盘植入谱系疾病不伴前置胎盘:系统综述与Meta分析

Pathologically diagnosed placenta accreta spectrum without placenta previa: a systematic review and meta-analysis.
PubMed 文献 · Am J Obstet Gynecol MFM · 2023-05-19

该系统综述与Meta分析检索了PubMed、Cochrane数据库和Web of Science从建库至2022年9月7日的文献,最终纳入5项研究,其中4项进入Meta分析。结果显示,不伴前置胎盘的胎盘植入谱系疾病(PAS)较伴前置胎盘者侵入性胎盘、出血量和子宫切除风险更低,产前诊断更困难;辅助生殖技术和既往子宫手术是不伴前置胎盘PAS的强危险因素,而既往剖宫产是伴前置胎盘PAS的强危险因素。

要点

  • 不伴前置胎盘的PAS较伴前置胎盘者侵入性胎盘风险更低(OR 0.24,95%CI 0.16-0.37)。
  • 不伴前置胎盘的PAS较伴前置胎盘者出血量更少(均差 -1.19,95%CI -2.09至-0.28)。
  • 不伴前置胎盘的PAS较伴前置胎盘者子宫切除风险更低(OR 0.11,95%CI 0.02-0.53),产前诊断更困难(OR 0.13,95%CI 0.04-0.45)。

核心结论

  • 需要理解伴与不伴前置胎盘的胎盘植入谱系疾病在临床方面的差异。

研究设计与样本

  • 系统综述与Meta分析,检索PubMed、Cochrane数据库和Web of Science从建库至2022年9月7日的文献。
  • 初检2598项研究,最终纳入5项研究进行综述,其中4项(排除1项研究)进入Meta分析。
  • 纳入标准为评估病理诊断的PAS不伴前置胎盘的临床表现的研究;主要结局为侵入性胎盘(包括植入或穿透)、出血量、子宫切除和产前诊断。
  • 同时调查母亲年龄、辅助生殖技术、既往剖宫产和既往子宫手术作为潜在危险因素;采用随机效应模型进行主要分析。

主要发现

  • 不伴前置胎盘的PAS较伴前置胎盘者侵入性胎盘风险更低(OR 0.24,95%CI 0.16-0.37)。
  • 不伴前置胎盘的PAS较伴前置胎盘者出血量更少(均差 -1.19,95%CI -2.09至-0.28)。
  • 不伴前置胎盘的PAS较伴前置胎盘者子宫切除风险更低(OR 0.11,95%CI 0.02-0.53)。
  • 不伴前置胎盘的PAS较伴前置胎盘者产前诊断更困难(OR 0.13,95%CI 0.04-0.45)。
  • 辅助生殖技术和既往子宫手术是不伴前置胎盘PAS的强危险因素,而既往剖宫产是伴前置胎盘PAS的强危险因素。

关键数值与推荐

  • 不伴前置胎盘的PAS与侵入性胎盘风险降低相关(OR 0.24,95%CI 0.16-0.37)。
  • 不伴前置胎盘的PAS与出血量减少相关(均差 -1.19,95%CI -2.09至-0.28)。
  • 不伴前置胎盘的PAS与子宫切除风险降低相关(OR 0.11,95%CI 0.02-0.53)。
  • 不伴前置胎盘的PAS与产前诊断更困难相关(OR 0.13,95%CI 0.04-0.45)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: This systematic review and meta-analysis aimed to assess clinical characteristics related to pathologically proven placenta accreta spectrum without placenta previa. DATA SOURCES: A literature search of PubMed, the Cochrane database, and Web of Science was performed from inception to September 7, 2022. STUDY ELIGIBILITY CRITERIA: The primary outcomes were invasive placenta (including increta or percreta), blood loss, hysterectomy, and antenatal diagnosis. In addition, maternal age, assisted reproductive technology, previous cesarean delivery, and previous uterine procedures were investigated as potential risk factors. The inclusion criteria were studies evaluating the clinical presentation of pathologically diagnosed PAS without placenta previa. METHODS: Study screening was conducted after duplicates were identified and removed. The quality of each study and the publication bias were assessed. Forest plots and I2 statistics were calculated for each study outcome for each group. The main analysis was a random-effects analysis. RESULTS: Among 2598 studies that were initially retrieved, 5 were included in the review. With the exception of 1 study, 4 studies were included in the meta-analysis. This meta-analysis showed that placenta accreta spectrum without placenta previa was associated with less risk of invasive placenta (odds ratio, 0.24; 95% confidence interval, 0.16-0.37), blood loss (mean difference, -1.19; 95% confidence interval, -2.09 to -0.28) and hysterectomy (odds ratio, 0.11; 95% confidence interval, 0.02-0.53), and more difficult to diagnose prenatally (odds ratio, 0.13; 95% confidence interval, 0.04-0.45) than placenta accreta spectrum with placenta previa. In addition, assisted reproductive technology and a previous uterine procedure were strong risk factors for placenta accreta spectrum without placenta previa, whhereas previous cesarean delivery was a strong risk factor for placenta accreta spectrum with placenta previa. CONCLUSION: The differences in clinical aspects of placenta accreta spectrum with and without placenta previa need to be understood.

来源:Am J Obstet Gynecol MFM,查看原文。版权归原作者所有。

引用

  1. Sugai S, Yamawaki K, Sekizuka T, et al. Pathologically diagnosed placenta accreta spectrum without placenta previa: a systematic review and meta-analysis. Am J Obstet Gynecol MFM. 2023. PMID: 37211089. doi:10.1016/j.ajogmf.2023.101027

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。